-
Adderall XR
- amphetamine + dextroamphetamine
- CNS Stimulant/ADHD
- C-II
- stimulates CNS activity; blocks reuptake and increases release of norepinephrine and dopamine in extraneuronal space (sympathomimetic)
- BBW: high potential for abuse
- SE: loss of appetite, xerostomia, insomnia, HA, weight loss
-
amphetamine + dextroamphetamine
- Adderall XR
- CNS Stimulant/ADHD
- C-II
- stimulates CNS activity; blocks reuptake and increases release of norepinephrine and dopamine in extraneuronal space (sympathomimetic)
- BBW: high potential for abuse
- SE: loss of appetite, xerostomia, insomnia, HA, weight loss
-
Detrol LA
- tolterodine
- Antimuscarinic
- Urinary Antispasmodic
- a competitive muscarinic receptor antagonist, has a high binding affinity for the cholinergic muscarinic receptors that mediates contraction of the urinary bladder, increasing the residual urine, and enhances salivation
- SE: xerostomia, HA, constipation
-
tolterodine
- Detrol LA
- Antimuscarinic
- Urinary Antispasmodic
- a competitive muscarinic receptor antagonist, has a high binding affinity for the cholinergic muscarinic receptors that mediates contraction of the urinary bladder, increasing the residual urine, and enhances salivation
- SE:
xerostomia, HA, constipation
-
Vyvanse
- lisdexamfetamine
- CNS Stimulant/Amphetamine (class)
- C-II
- lisdexamfetamine dimesylate is rapidly absorbed and converted to the active drug dextroamphetamine; may block the reuptake of norepinephrine and dopamine
- BBW: high potential for abuse
- SE: loss of appetite, xerostomia, insomnia, HA, weight loss
-
lisdexamfetamine
- Vyvanse
- CNS Stimulant/Amphetamine (class)
- C-II
- lisdexamfetamine dimesylate is rapidly absorbed and converted to the active drug dextroamphetamine; may block the reuptake of norepinephrine and dopamine
- BBW: high potential for abuse
- SE: loss of appetite, xerostomia, insomnia, HA, weight loss
-
Toprol XL
- metoprolol succinate
- Beta-Adrenergic Blocker, Cardioselective
- Cardiovascular Agent
- a beta-adrenergic blocker with selective activity on beta(1) adrenoreceptors located mainly in cardiac muscles. At higher doses, it also inhibits beta(2) adrenoreceptors of bronchial and vascular smooth muscles.
- BBW: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred
- SE: dizziness, fatigue, pruritus
-
metoprolol succinate
- Toprol XL
- Beta-Adrenergic Blocker, Cardioselective
- Cardiovascular Agent
- a beta-adrenergic blocker with selective activity on beta(1) adrenoreceptors located mainly in cardiac muscles. At higher doses, it also inhibits beta(2) adrenoreceptors of bronchial and vascular smooth muscles.
- BBW: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred
- SE: dizziness, fatigue, pruritus
-
Aciphex
- rabeprazole
- Gastric Acid Secretion Inhibitor
- Proton Pump Inhibitor
- suppresses gastric acid secretion by inhibiting the gastric H+, K+-ATPase at the secretory surface of parietal cells
- SE: abdominal pain, HA, diarrhea, N/V
-
rabeprazole
- Aciphex
- Gastric Acid Secretion Inhibitor
- Proton Pump Inhibitor
- suppresses gastric acid secretion by inhibiting the gastric H+, K+-ATPase at the secretory surface of parietal cells
- SE: abdominal pain, HA, diarrhea, N/V
-
NuvaRing
- ethinyl estradiol + etonogestrel
- Contraceptives (vaginal insert)
- suppression of gonadotropins to inhibit of ovulation
- BBW: Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use.
- SE: weight gain, sinusitis, upper resp infection
-
ethinyl estradiol + etonogestrel
- NuvaRing
- Contraceptives (vaginal insert)
- suppression of gonadotropins to inhibit of ovulation
- BBW: Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use.
- SE: weight gain, sinusitis, upper resp infection
-
Flovent HFA
- fluticasone
- Antiasthmatic
- Corticosteroid (intermediate), Anti-Inflammatory
- inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects
- SE: HA, upper resp infect, oral candidiasis
-
fluticasone
- Flovent HFA
- Antiasthmatic
- Corticosteroid (intermediate), Anti-Inflammatory
- inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects
- SE: HA, upper resp infect, oral candidiasis
-
Avapro
- irbesartan
- Angiotensin II Receptor Antagonist (ARB)
- Antihypertensive
- selectively blocks the binding of angiotensin II to the AT 1 receptor
- BBW: fetal death
- SE: HA, fatigue
-
irbesartan
- Avapro
- Angiotensin II Receptor Antagonist (ARB)
- Antihypertensive
- selectively blocks the binding of angiotensin II to the AT 1 receptor
- BBW: fetal death
- SE: HA, fatigue
-
Combivent
- albuterol + ipratropium
- Bronchodilator
- Beta-2 Agonists/Short-acting inhaled
- combination reduces bronchospasm through both sympathomimetic and anticholinergic mechanisms. Simultaneous administration of both drugs produces a greater bronchodilator effect than when either drug is used alone at recommended dosages.
- SE: HA, upper resp depression, bronchitis, dyspnea
-
albuterol + ipratropium
- Combivent
- Bronchodilator
- Beta-2 Agonists/Short-acting inhaled
- combination reduces bronchospasm through both sympathomimetic and anticholinergic mechanisms. Simultaneous administration of both drugs produces a greater bronchodilator effect than when either drug is used alone at recommended dosages.
- SE: HA, upper resp depression, bronchitis, dyspnea
-
Boniva
- ibandronate
- Osteoporosis agent
- bisphosphonates
- inhibits osteoclast-mediated bone resorption and turnover leading to a net gain in bone mass
- SE: upper resp infection, hypertension, indigestion, N/V
-
ibandronate
- Boniva
- Osteoporosis agent
- bisphosphonates
- inhibits osteoclast-mediated bone resorption and turnover leading to a net gain in bone mass
- SE: upper resp infection, hypertension, indigestion, N/V
|
|
